|
Sept. 5, 2008 -- A new analysis by the American Lung Association does not support a link between the asthma and allergy drug Singulair and depression and suicide .
|
|
... federally-funded program to discover new drugs to combat influenza infection. Sponsored by the National Institute of Allergy and Infectious Diseases, Integral Molecular's R&D program will utilize its proprietary Lipoparticle technology to discover ...
|
|
... on the American side of the border. For two of the drugs--Enbrel, for rheumatoid arthritis, and Nasonex, an allergy treatment--there was no change in sales after the campaigns started. A third drug for irritable bowel syndrome, Zelnorm, did ...
|
|
... significant insomnia. And many-like Nytol, Simply Sleep, Sominex, and Unisom-contain antihistamines (similar to the allergy medicine Benadryl) that can have side effects like dry mouth and eyes and next-day grogginess, says Donna Arand, PhD, ...
|
|
... it will trim 17 percent of its work force - about 2,000 employees - in order to reestablish the company as specialty drug firm. UCB's restructuring plan, dubbed "SHAPE," will allow the Belgian-based company to concentrate on central nervous system ...
|
|
There's no evidence that using the allergy/asthma drug Singulair increases the risk of depression or suicide, according to a review of data from three clinical trials.
|
|
... the Office of the Biomedical Advanced Research and Development Authority (BARDA), and the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The four year contract provides funding ...
|
|
... and malaria , joining HIV and TB, which have been held over from round one. Also back is the search for overcoming drug resistance , a serious problem not only in tuberculosis in but "superbugs" like Methicillin-resistant Staphylococcus aureus ...
|
|
... of prescription drugs continues to rise, but a new study suggests it might not always be a wise investment. Drug companies spent an estimated $4.24 billion on direct-to-consumer, or DTC, ads in 2005 -- more than triple what they spent in 1996, ...
|
|
... sold by Wyeth and Amgen to treat rheumatoid arthritis and other conditions; Novartis AG's now-withdrawn irritable bowel drug Zelnorm; and the Nasonex allergy treatment made by ScheringPlough Corp. These three drugs were on the market for at least a ...
|
|
To the allergy-free person, red eyes and stuffy noses may look like mild discomforts amplified by whiners and drug companies.
|
|
Cheap generic copies of brand name drugs took a bite out of sales at Longs Drug Stores Corp.
|
|
UCB announced today that it received a not-approvable letter from the U.S. Food and Drug Administration for lacosamide for the treatment of diabetic neuropathic pain in adults.
|